Synaptogenix Stock Market Value
| SNPX Stock | USD 2.60 0.03 1.17% |
| Symbol | Synaptogenix |
Synaptogenix Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Synaptogenix. If investors know Synaptogenix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Synaptogenix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 10.27 | Return On Assets (0.14) | Return On Equity (0.07) |
The market value of Synaptogenix is measured differently than its book value, which is the value of Synaptogenix that is recorded on the company's balance sheet. Investors also form their own opinion of Synaptogenix's value that differs from its market value or its book value, called intrinsic value, which is Synaptogenix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Synaptogenix's market value can be influenced by many factors that don't directly affect Synaptogenix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Synaptogenix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Synaptogenix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Synaptogenix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Synaptogenix 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Synaptogenix's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Synaptogenix.
| 02/27/2024 |
| 11/23/2024 |
If you would invest 0.00 in Synaptogenix on February 27, 2024 and sell it all today you would earn a total of 0.00 from holding Synaptogenix or generate 0.0% return on investment in Synaptogenix over 270 days. Synaptogenix is related to or competes with Annovis Bio, Cyclo Therapeutics, Reviva Pharmaceuticals, INmune Bio, and Alzamend Neuro. Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical developm... More
Synaptogenix Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Synaptogenix's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Synaptogenix upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 31.39 | |||
| Value At Risk | (8.05) | |||
| Potential Upside | 10.33 |
Synaptogenix Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Synaptogenix's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Synaptogenix's standard deviation. In reality, there are many statistical measures that can use Synaptogenix historical prices to predict the future Synaptogenix's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.64) | |||
| Total Risk Alpha | (1.25) | |||
| Treynor Ratio | (0.23) |
Synaptogenix Backtested Returns
Synaptogenix owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0769, which indicates the firm had a -0.0769% return per unit of risk over the last 3 months. Synaptogenix exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Synaptogenix's Coefficient Of Variation of (1,305), risk adjusted performance of (0.05), and Variance of 28.02 to confirm the risk estimate we provide. The entity has a beta of 1.83, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Synaptogenix will likely underperform. At this point, Synaptogenix has a negative expected return of -0.41%. Please make sure to validate Synaptogenix's treynor ratio, accumulation distribution, as well as the relationship between the Accumulation Distribution and price action indicator , to decide if Synaptogenix performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.49 |
Average predictability
Synaptogenix has average predictability. Overlapping area represents the amount of predictability between Synaptogenix time series from 27th of February 2024 to 11th of July 2024 and 11th of July 2024 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Synaptogenix price movement. The serial correlation of 0.49 indicates that about 49.0% of current Synaptogenix price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.49 | |
| Spearman Rank Test | 0.55 | |
| Residual Average | 0.0 | |
| Price Variance | 0.26 |
Synaptogenix lagged returns against current returns
Autocorrelation, which is Synaptogenix stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Synaptogenix's stock expected returns. We can calculate the autocorrelation of Synaptogenix returns to help us make a trade decision. For example, suppose you find that Synaptogenix has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Synaptogenix regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Synaptogenix stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Synaptogenix stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Synaptogenix stock over time.
Current vs Lagged Prices |
| Timeline |
Synaptogenix Lagged Returns
When evaluating Synaptogenix's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Synaptogenix stock have on its future price. Synaptogenix autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Synaptogenix autocorrelation shows the relationship between Synaptogenix stock current value and its past values and can show if there is a momentum factor associated with investing in Synaptogenix.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Synaptogenix Stock Analysis
When running Synaptogenix's price analysis, check to measure Synaptogenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synaptogenix is operating at the current time. Most of Synaptogenix's value examination focuses on studying past and present price action to predict the probability of Synaptogenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synaptogenix's price. Additionally, you may evaluate how the addition of Synaptogenix to your portfolios can decrease your overall portfolio volatility.